Word

FOXO LABS

Status

Pending

Status Code

688

Status Date

Tuesday, September 26, 2023

Serial Number

88732538

Mark Type

4000

Filing Date

Wednesday, December 18, 2019

Published for Opposition

Tuesday, May 9, 2023

Trademark Owner History

FOXO TECHNOLOGIES INC. - Owner At Publication
FOXO BIOSCIENCE LLC - 1st New Owner Before Publication
Insurtech Holdings, LLC - Original Applicant

Classifications

41 Providing an online resource center, namely, online non-downloadable articles and papers in the fields of longevity, aging, genetic and epigenetic testing and genotyping and genomic technologies; Providing a website featuring online non-downloadable publications in the nature of articles, journals, brochures, leaflets, guides and manuals in the fields of longevity, aging, genetic and epigenetic testing and genotyping and genomic technologies; Providing an online publication in the nature of an non-downloadable interactive encyclopedia in the fields of longevity, aging, genetic and epigenetic testing and genotyping and genomic technologies; Educational services, namely, providing seminars, workshops, customer trainings and tutorials in the fields of, and for use in the fields of, health and aging tips and strategies, disease prevention, nucleic acid sequencing, genetics, epigenetics, genotyping, genomics, metagenomics, medical diagnostics, veterinary diagnostics, clinical diagnostics, medical research, veterinary research, clinical research, drug development, drug development research, medical laboratory research, veterinary science and research, life sciences, biology, microbiology, biotechnology, agriculture, forensics, food safety, population research, and actuarial services; Providing non-downloadable electronic newsletters and online non-downloadable electronic newsletters delivered via email for use in the fields of health and aging tips and strategies, disease prevention, nucleic acid sequencing, genetics, epigenetics, genotyping, genomics, metagenomics, medical diagnostics, veterinary diagnostics, clinical diagnostics, medical research, veterinary research, clinical research, drug development, drug development research, medical laboratory research, veterinary science and research, life sciences, biology, microbiology, biotechnology, agriculture, forensics, food safety, population research, and actuarial services; Educational services, namely, providing training of clinicians, scientists, researchers and medical professionals in the use of scientific equipment, instruments and techniques, namely, genomic sequencers, molecular diagnostic technologies, microarray technologies, DNA extraction, bioinformatics, and automated laboratory apparatus; Providing facilities for training in operation and use of scientific equipment, instruments and techniques, namely, genomic sequencers, molecular diagnostic technologies, microarray technologies, DNA extraction, bioinformatics, and automated laboratory apparatus

9 Computer systems, namely, computer hardware, downloadable computer software, and downloadable electronic data files for collecting, storing, analyzing and reporting biological information, and for sample tracking and managing projects, laboratory workflow and data, all the foregoing for use in the fields of diagnostic and clinical research and for clinical diagnostic purposes, and excluding software that facilitates communication, collaboration, networking and the sharing of medical information and imaging between medical professionals with other medical professionals and medical service providers; Downloadable computer software for data collection, management, and analysis of molecular health, genetic and epigenetic information for use in the fields of diagnostic and clinical research and for clinical diagnostic purposes, excluding software that facilitates communication, collaboration, networking and the sharing of medical information and imaging between medical professionals with other medical professionals and medical service providers

5 Medical diagnostic reagents; Clinical medical diagnostic reagents

1 Epigenetic test kits comprising reagents for testing and analyzing saliva for non-medical purposes; Reagent kits and beads with attached biomolecules, comprised primarily of oligonucleotides and other nucleic acids, natural and modified nucleotides, polypeptides, buffers, labels, and substrates, for clinical diagnostic purposes

45 Online social networking services in the field of longevity, aging, genetics and epigenetics

44 Medical testing for screening, diagnostic or prognostic purposes; DNA sequencing, screening, and analysis services for medical diagnostic purposes; Nucleic acid sequencing, screening, and analysis services for medical diagnostic purposes; Genomic sequencing, screening, and analysis services for medical diagnostic purposes; Genetic and epigenetic analysis and reporting services for medical diagnostic purposes; Medical diagnostic testing, monitoring and reporting services in the field of infectious disease identification and surveillance

42 Providing scientific analysis in the field of personal epigenetics; Reporting of consumer authorized molecular health, aging and longevity results direct to the consumer for non-medical purposes, namely, epigenetic testing, analysis and evaluation of saliva; Testing, analysis and evaluation of DNA for epigenetic patterns associated with alcohol and tobacco use and other traits about an individual for non-medical purposes; Providing an interactive website featuring technology that allows users to enter, access, track, monitor and generate information and reports in the fields of personal epigenetics, health and wellness

"LABS"

Trademark Events

Sep 26, 2023

Noa E-Mailed - Sou Required From Applicant

Aug 14, 2023

Extension Of Time To Oppose Process - Terminated

Jun 1, 2023

Extension Of Time To Oppose Received

May 9, 2023

Official Gazette Publication Confirmation E-Mailed

May 9, 2023

Published For Opposition

Apr 19, 2023

Notification Of Notice Of Publication E-Mailed

Apr 3, 2023

Approved For Pub - Principal Register

Mar 30, 2023

Teas/Email Correspondence Entered

Mar 29, 2023

Correspondence Received In Law Office

Mar 29, 2023

Teas Request For Reconsideration Received

Jan 3, 2023

Notification Of Final Refusal Emailed

Jan 3, 2023

Final Refusal E-Mailed

Jan 3, 2023

Final Refusal Written

Nov 18, 2022

Preliminary/Voluntary Amendment - Entered

Nov 18, 2022

Teas Voluntary Amendment Received

Oct 28, 2022

Teas/Email Correspondence Entered

Oct 27, 2022

Correspondence Received In Law Office

Oct 27, 2022

Teas Response To Office Action Received

Apr 27, 2022

Notification Of Non-Final Action E-Mailed

Apr 27, 2022

Non-Final Action E-Mailed

Apr 27, 2022

Non-Final Action Written

Mar 31, 2022

Teas/Email Correspondence Entered

Mar 30, 2022

Correspondence Received In Law Office

Mar 30, 2022

Teas Response To Office Action Received

Nov 17, 2021

Teas Change Of Correspondence Received

Nov 17, 2021

Teas Withdrawal Of Attorney Received-Firm Retains

Nov 17, 2021

Attorney/Dom.Rep.Revoked And/Or Appointed

Nov 17, 2021

Teas Revoke/App/Change Addr Of Atty/Dom Rep Received

Sep 30, 2021

Notification Of Non-Final Action E-Mailed

Sep 30, 2021

Non-Final Action E-Mailed

Sep 30, 2021

Non-Final Action Written

Aug 30, 2021

Suspension Checked - To Attorney For Action

Aug 12, 2021

Assigned To Examiner

Jul 30, 2021

Suspension Checked - To Attorney For Action

Jul 9, 2021

Applicant/Correspondence Changes (Non-Responsive) Entered

Jul 9, 2021

Teas Change Of Correspondence Received

Jul 9, 2021

Teas Withdrawal Of Attorney Received-Firm Retains

Jul 9, 2021

Attorney/Dom.Rep.Revoked And/Or Appointed

Jul 9, 2021

Teas Revoke/App/Change Addr Of Atty/Dom Rep Received

Jul 9, 2021

Teas Change Of Owner Address Received

May 19, 2021

Automatic Update Of Assignment Of Ownership

Oct 14, 2020

Notification Of Letter Of Suspension E-Mailed

Oct 14, 2020

Letter Of Suspension E-Mailed

Oct 14, 2020

Suspension Letter Written

Sep 22, 2020

Teas/Email Correspondence Entered

Sep 21, 2020

Correspondence Received In Law Office

Sep 21, 2020

Teas Response To Office Action Received

Mar 25, 2020

Automatic Update Of Assignment Of Ownership

Mar 21, 2020

Notification Of Non-Final Action E-Mailed

Mar 21, 2020

Non-Final Action E-Mailed

Mar 21, 2020

Non-Final Action Written

Mar 17, 2020

Assigned To Examiner

Dec 23, 2019

New Application Office Supplied Data Entered

Dec 21, 2019

New Application Entered